J Bacteriol 2002, 184: 5479–5490.PubMedCrossRef 3. Hughes AL, Friedman R, Murray M: Genomewide pattern of synonymous nucleotide substitution in two complete genomes of Mycobacterium tuberculosis . Emerg Infect Dis 2002, 8: 1342–1346.PubMed 4. Gao Q, Kripke KE, Saldanha AJ, Yan W, Holmes S, Small PM: Gene expression diversity among Mycobacterium tuberculosis clinical isolates. Microbiology 2005, 151: 5–14.PubMedCrossRef

5. Domenech P, Boshoff HI, Reed MB, Manca C, Kaplan G, Barry CE III: In vivo phenotypic dominance in mouse mixed infections with Mycobacterium tuberculosis clinical isolates. J Infect Dis 2005, 192: 600–606.PubMedCrossRef 6. Manca C, Tsenova L, Bergtold A, Freeman S, Tovey M, Musser JM, Barry CE III, Freedman

VH, Kaplan G: Virulence of a Mycobacterium Seliciclib cost tuberculosis clinical isolate in mice is determined by failure to induce Th1 type immunity and is associated with induction of IFN-alpha/beta. Proc Natl Acad Sci USA 2001, 98: 5752–5757.PubMedCrossRef 7. Bellamy R, Ruwende selleck chemicals llc C, Corrah T, McAdam KP, Whittle HC, Hill AV: Variations in the NRAMP1 gene and susceptibility to tuberculosis in West Africans. N Engl J Med 1998, 338: 640–644.PubMedCrossRef 8. Weiss RA, McMichael AJ: Social and environmental risk factors in the emergence of infectious diseases. Nat Med 2004, 10: S70-S76.PubMedCrossRef 9. Kumar A, Bose M, Brahmachari V: Analysis of expression profile of mammalian cell entry ( mce ) operons of Mycobacterium tuberculosis . Infect Immun 2003, 71: 6083–6087.PubMedCrossRef 10. Aguilar LD, Infante E, Bianco MV, Cataldi A, Bigi F, Pando RH: Immunogenicity and protection induced by Mycobacterium tuberculosis mce-2 and mce-3 mutants in a Balb/c mouse model of progressive pulmonary tuberculosis. Vaccine 2006, 24: 2333–2342.PubMedCrossRef 11. Cole ST, Brosch R, Parkhill J, Garnier T, Churcher

C, Harris D, Gordon SV, Eiglmeier K, Gas S, Barry CE III, Tekaia F, Badcock K, Basham D, Brown D, Chillingworth T, Connor R, Davies R, Devlin K, Feltwell T, Gentles S, Hamlin N, Holroyd S, Hornsby T, Jagels K, Krogh A, McLean J, Moule S, Murphy L, Oliver K, Osborne J, Quail MA, Rajandream MA, Rogers J, Rutter S, Seeger K, Skelton J, Squares R, Squares Mephenoxalone S, Sulston JE, Taylor K, Whitehead S, Barrell BG: Deciphering the biology of Mycobacterium tuberculosis from the complete genome sequence. Nature 1998, 393: 537–544.PubMedCrossRef 12. Sassetti CM, Rubin EJ: Genetic requirements for mycobacterial survival during infection. Proc Natl Acad Sci USA 2003, 100: 12989–12994.PubMedCrossRef 13. Ahmad S, Akbar PK, Wiker HG, Harboe M, Mustafa AS: Cloning, expression and immunological reactivity of two mammalian cell entry proteins encoded by the mce1 operon of Mycobacterium tuberculosis . Scand J Immunol 1999, 50: 510–518.PubMedCrossRef 14.

It is clinically relevant to be able to predict to what extent a patient will respond to PTH in order to determine the best treatment. In a clinical study, several characteristics like BMD before treatment and age were examined for correlations with the increase in BMD after PTH treatment; however, no strong correlations were found [44]. In our study, the best predictor of final bone mass and bone volume fraction in both the meta- and epiphysis

was bone mass and FXR agonist bone volume fraction at the start of the experiment, before ovariectomy. If these results would be translational to clinical practice, which needs to be tested, this would indicate that bone mineral density before menopause would predict bone mineral density after PTH treatment of osteoporotic patients. find more Cortical bone mass increased linearly over time after PTH treatment in the meta- and diaphysis while marrow cavity volume decreased. In several cross-sectional studies, in which the effect of between 8 weeks and 6 months of PTH treatment was evaluated in ovariectomized rats, an increase in cortical bone mass was found [6, 14, 38]. In a study in ovariectomized mice, it was found that

within 3 weeks of PTH treatment, cortical thickness was significantly increased in the metaphysis and after 7 weeks, cortical thickness was even higher [45]. Diaphyseal cortical thickness was significantly increased only after 7 weeks of treatment. In another study, the effects of PTH treatment on metaphyseal cortical thickness of the tibia in ovariectomized rats was studied over time by using peripheral quantitative computed tomography

(pQCT) [46]. A linear increase in cortical thickness was found until about 6 weeks, after which the effect reached a plateau. Taken together, our linear increase in dia- and metaphyseal cortical bone after PTH treatment agrees with the literature. In the metaphysis, no effect of ovariectomy was found on cortical bone parameters, which agrees with previous studies [47, 48]. Interestingly, cortical thickness and polar moment of inertia in the diaphysis increased after ovariectomy, which is in contrast to significant decreases [21, 49] and no significant 3-mercaptopyruvate sulfurtransferase changes [50, 51] previously reported. It has previously been found that PTH leads to a predominance of endocortical over periosteal bone apposition in cortical bone [16–18, 52]. Based on registered images of weeks 8 and 14, before and after PTH treatment, we found that endosteal and periosteal bone apposition both took place in the meta- and diaphysis, with a slight predominance of endosteal formation in the former one and a slight predominance of periosteal formation in the latter one. This difference between the meta- and diaphysis could be related to the following.

For example, if we wish to discern whether the biofilm is responding to iron limitation, we first identify a set of genes that are up-regulated in response to iron deprivation (e.g. the work of Ochsner [9]). The rank of each of these transcripts in the biofilm data set is then compared to transcript ranks for the same genes in data sets collected from both rapidly

growing and deliberately iron-starved cultures. In this way it becomes possible to evaluate physiological activities in the biofilm rather than just documenting differences between the biofilm and a reference state. In the experiments reported here, RNA was extracted from an entire, homogenized biofilm specimen. An obvious concern with this approach is that it neglects the inherent biological Vemurafenib heterogeneity of the biofilm [1]. We would like to address this concern upfront with two points. First, just because a population is heterogeneous

does not mean that measurements of population averages are invalid. Population averages are very widely and informatively used in biology. Second, we suggest that even the concept of an average may not be appropriate in this case. The current conceptual model of P. aeruginosa drip-flow biofilms is that they consist of two distinct populations: an aerobic, metabolically active upper layer and a lower, and larger, layer consisting of inactive Palbociclib cells containing very low levels of mRNA [10, 11]. Because the inactive cells contain so little RNA, this majority is expected to be essentially invisible on the microarray. From this perspective, the transcriptomes reported here may best be thought of as reflecting the properties of the transcriptionally-active subpopulation rather than the average behavior of the entire population. These concepts are elaborated on in the Results PAK5 and Discussion. Results and Discussion Three day old drip flow biofilms of P. aeruginosa were characterized with respect to antibiotic tolerance, oxygen availability, and microscale patterns of protein synthetic activity. These biofilms

contained 9.56 ± 0.31 cfu cm-2. Reduced antibiotic susceptibility of biofilm bacteria P. aeruginosa cells grown in biofilms were protected from killing by tobramycin and ciprofloxacin, in comparison to actively growing planktonic bacteria. Both antibiotics rapidly and effectively reduced viable cell numbers in an aerobic, planktonic culture. After 12 h of treatment with 10 μg ml-1 tobramycin or 1.0 μg ml-1 ciprofloxacin, planktonic log reductions measured were 3.18 ± 1.79 (n = 3, ± SD) and 4.84 ± 0.55 (n = 3, ± SD) for tobramycin and ciprofloxacin, respectively. In contrast, neither antibiotic was very effective against biofilms of P. aeruginosa. After 12 h exposure to antibiotic in continuously flowing medium, the log reductions in viable cell numbers were 0.72 ± 0.56 (n = 3, ± SD) and 1.37 ± 0.06 (n = 3, ± SD) for tobramycin and ciprofloxacin, respectively.

Diagn Microbiol Infect Dis 2012,73(3):243–245.PubMedCentralPubMedCrossRef 87. Anderson JF, Armstrong PM: Prevalence and genetic characterization of Powassan

virus strains infecting Ixodes scapularis in Connecticut. Am J Trop Med Hyg 2012,87(4):754–759.PubMedCrossRef 88. Raval M, Singhal M, Guerrero D, Alonto A: Powassan virus infection: case series and literature review from a single institution. BMC Res Notes 2012, 5:594.PubMedCentralPubMedCrossRef 89. Ytrehus B, Vainio K, Dudman SG, Gilray J, Willoughby K: Tick-borne encephalitis virus and louping-Ill virus may co-circulate in Southern Norway. Vector Borne Zoonotic Dis 2013,13(10):762–768.PubMedCrossRef Competing Compound Library clinical trial interests None of the authors have competing personal or financial interests relevant to the publication of this manuscript. We want to disclose that S.A.E.M. is among a group of inventors who earn royalties find more for molecular beacon usage. Authors’ contribution KC and NP designed the experiments, SAEM designed the molecular beacons and KC conducted the experiments. NP drafted the manuscript. All authors read and approved the final manuscript.”
“Background The commercial importance of the actinomycete Streptomyces clavuligerus lies in its ability to produce several secondary metabolites of therapeutic interest

[1]. Among these compounds are: cephamycin C, a beta-lactam antibiotic more resistant to beta-lactamases than the structurally similar antibiotic cephalosporin C produced by filamentous fungi, and for this reason used as raw material for production of semi-synthetic antibiotics (cefotetan, cefoxitin, cefmetazole, and temocillin) [2, 3]; clavulanic acid, a beta-lactamases inhibitor whose use in conjunction with amoxicillin is the most important commercial example [4]; other clavams, which have antifungal properties [5]; and non-beta-lactam compounds such as

holomycin and tunicamycin, which have antibiotic and antitumor properties [5–7]. The biosynthetic diversity inherent to S. clavuligerus results in extremely complex metabolic regulation [8–14], which has led to different studies aimed at increasing the biosynthesis of relevant biocompounds. Among these compounds, cephamycin C has been one of the most extensively investigated [15–23]. The basic structure of this biocompound and of all other Cepharanthine beta-lactam antibiotics produced by prokaryotes or eukaryotes derives from L-cysteine, L-valine, and L-alpha-aminoadipic acid. In prokaryotes, alpha-aminoadipic acid is the product of lysine degradation via 1-piperideine-6-carboxylate [24–26]. The use of exogenous lysine to enhance cephamycin C biosynthesis in cultures of producer species has been known for over thirty years [16, 20, 23, 27, 28]. Studies have shown that high lysine concentrations (above 50 mmol l-1) promote higher cephamycin C production as compared to that of culture media containing little or no lysine.

WT and arcA mutant Salmonella were grown in LB-MOPS-X broth to stationary phase for about 20 h.

check details For intraperitoneal (i.p.) challenge, two groups of five mice per strain (WT and arcA mutant) were inoculated with 250 CFU in 500 μl PBS/mouse. Mortality was scored over a 15- to 30-day period. Competitive infection assays were carried-out as described [33] with modifications. The strains were separately grown overnight in LB broth at 37°C with shaking at 200 rpm. Tetracycline (10 μg/ml) was used to propagate and isolate the arcA mutant. Bacterial (i. e.: WT and arcA mutant) cultures were diluted in phosphate-buffered saline (PBS) and mixed to produce a 1:1 inoculum ratio. Groups of mice were infected either i.p. or orally (p.o.). Prior to oral infection, food and water were withheld from the mice for 4 h and the bacterial cocktail was administered to the mice by allowing them to drink 20 μl from the end Tamoxifen research buy of a pipette tip. On day 4 or day 6 after i.p. or p.o. infection, respectively, mice were euthanized and mesenteric lymph nodes (MLN), liver and spleen collected for bacterial enumeration. The tissues were homogenized in sterile PBS and 10-fold serial dilutions were plated

on LB agar medium with or without 10 μg/mL tetracycline to distinguish the WT (Tets) from the arcA mutant (Tetr). The number of CFUs of S. Typhimurium 14028 s per organ was calculated by subtracting the number of CFU/ml on the LB-Tet plates from the number of CFU/ml on the corresponding LB plates. The competitive index (CI) was calculated as the ratio of the CFU of arcA mutant to the CFU of the WT strain recovered from the spleen, liver, and mesenteric lymph nodes (i.e.; CI = [arcA mutant/WT]output/[arcA mutant/WT]input). Results Bacterial growth kinetics The growth kinetics of the WT and the arcA mutant strains were determined under anaerobic conditions in LB-MOPS-X. The arcA mutant strain grew at a slower rate than the WT strain. The doubling-times of the WT and arcA mutant were 37.0 ± 0.4 and 55.4 ± 0.1 min under anaerobic

conditions. Due to the difference in the doubling-times of the two strains, cells used for RNA isolation and subsequent transcriptome profiling were allowed to grow for an equal number of generations (~five generations: OD600 = 0.30-0.35) instead of an equal length of time. Anaerobic transcriptome profiling Anidulafungin (LY303366) Out of 4,579 genes, the two-tailed Student’s t test, produced a set of 2,026 coding sequences showing a significant difference between the arcA mutant and the WT (p < 0.05). We restricted the analyses to only include highly affected genes (i.e., has a ratio ≥ 2.5-fold) as previously described [20]. Under this constraint, 392 genes were differentially expressed in the arcA mutant relative to the WT and, therefore, regulated directly or indirectly by ArcA. Of these, 147 genes were up-regulated and 245 genes were down-regulated (Additional file 1: Table S1).

Environ Microbiol 2001,3(6):363–370.PubMedCrossRef 53. Sachs JL, Kembel SW, Lau AH, Simms EL: In Situ Phylogenetic Structure and Diversity of Wild Bradyrhizobium Communities. Appl Environ Microbiol 2009,75(14):4727–4735.PubMedCrossRef 54. Thies JE, Singleton PW, Bohlool BB: Influence of the Size of Indigenous Rhizobial Populations on Establishment and Symbiotic Performance of Introduced Rhizobia on Field-Grown Legumes. Appl Environ Microbiol 1991,57(1):19–28.PubMed 55. Koonin EV, Aravind click here L, Kondrashov AS: The impact of comparative genomics on our understanding

of evolution. Cell 2000, 101:573–576.PubMedCrossRef 56. Mengoni A, Barabesi C, Gonnelli C, Galardi F, Bazzicalupo M: Genetic diversity of heavy metal-tolerant populations in Silene paradoxa L. (Caryophyllaceae): a chloroplast microsatellite analysis. Mol Ecol Raf activation 2001,10(8):1909–1916.PubMedCrossRef 57. Hammer Ø, Harper DAT, Ryan PD: PAST: Paleontological Statistics Software Package for Education and Data Analysis. Palaeontologia Electronica 2001,41(1):9. 58. Excoffier L, Smouse PE, Quattro M: Analysis of molecular variance inferred from metric distances among DNA haplotypes: application to human mitochondrial DNA restriction data. Genet 1992, 131:479–491. 59. Mocali S, Bertelli E, Di Cello F, Mengoni A, Sfalanga A, Viliani F, Caciotti A, Tegli S, Surico G, Fani R: Fluctuation of bacteria

isolated from elm tissues during different seasons and from different plant organs. Res Microbiol 2003,154(2):105–114.PubMedCrossRef 60. Slatkin M: A measure of population subdivision based on microsatellite allele frequencies. Genet 1995, 139:457–462. 61. Tamura K, Dudley J, Nei M, Kumar S: MEGA4: Molecular Evolutionary Genetics Analysis (MEGA) software version 4.0. Mol Biol Evol 2007, 24:1596–1599.PubMedCrossRef 62. Schloss PD, Westcott SL, Ryabin T, Hall JR, Hartmann M, Hollister EB, Lesniewski RA, Oakley BB, Parks DH, Robinson Thiamet G CJ, et al.: Introducing mothur: Open Source, Platform-independent, Community-supported

Software for Describing and Comparing Microbial Communities. Appl Environ Microbiol 2009,75(23):7537–7541.PubMedCrossRef 63. Good IJ: The population frequencies of species and the estimation to the population parameters. Biometrika 1953, 40:237–264. 64. Cole JR, Wang Q, Cardenas E, Fish J, Chai B, Farris RJ, Kulam-Syed-Mohideen AS, McGarrell DM, Marsh T, Garrity GM, et al.: The Ribosomal Database Project: improved alignments and new tools for rRNA analysis. Nucl Acids Res 2009,37(suppl_1):D141–145.PubMedCrossRef 65. Edgar RC: MUSCLE: a multiple sequence alignment method with reduced time and space complexity. BMC Bioinformatics 2004, 5:113.PubMedCrossRef Competing interests The authors declare that they have no competing interests. Authors’ contributions FP performed most of the analyses, prepared the figures and contributed in writing the draft of the manuscript. This work is part of FP PhD thesis.

PubMedCrossRef 22. Spyropoulos IC, Liakopoulos TD, Bagos PG, Hamodrakas SJ: TMRPres2D: high quality visual representation of transmembrane protein models. Bioinformatics 2004,20(17):3258–3260.PubMedCrossRef 23. Delpino MV, Marchesini MI, Estein SM, Comerci DJ, Cassataro J, Fossati CA, Baldi PC: A bile salt hydrolase of Brucella abortus contributes to the establishment of a successful infection through the oral route in mice. Infect

Immun 2007,75(1):299–305.PubMedCrossRef 24. Paixao TA, Roux CM, den Hartigh AB, Sankaran-Walters S, Dandekar S, Santos RL, Tsolis RM: Establishment of systemic Brucella melitensis infection through the digestive tract requires urease, the type IV secretion AT9283 chemical structure system, and lipopolysaccharide selleck screening library O-antigen. Infect Immun 2009,77(10):4197–4208.PubMedCrossRef 25. Sambrook J, Fritsch EF, Maniatis T: Molecular cloning: a laboratory manual. 2nd edition. Cold Spring Harbor, NY.: Cold Spring Harbor Laboratory Press; 1989.

26. Sangari FJ, Aguero J: Identification of Brucella abortus B19 vaccine strain by the detection of DNA polymorphism at the ery locus. Vaccine 1994,12(5):435–438.PubMedCrossRef 27. Vieira J, Messing J: The pUC plasmids, an M13 mp7-derived system for insertion mutagenesis and sequencing with synthetic universal primers. Gene 1982,19(3):259–268.PubMedCrossRef 28. Oka A, Sugisaki H, Takanami M: Nucleotide sequence of the kanamycin resistance transposon Tn 903 . J Mol Biol 1981,147(2):217–226.PubMedCrossRef 29. Walhout AJ, Temple GF, Brasch MA, Hartley JL, Lorson MA, Heuvel S, Vidal M: GATEWAY recombinational cloning: application to the cloning of large numbers of open reading frames or ORFeomes. Methods Enzymol 2000, 328:575–592.PubMedCrossRef 30. Dricot A, Rual JF, Lamesch P, Bertin N, Dupuy Org 27569 D, Hao T, Lambert C, Hallez R, Delroisse JM, Vandenhaute J, et al.: Generation

of the Brucella melitensis ORFeome Version 1.1. Genome Res 2004,14(10B):2201–2206.PubMedCrossRef 31. Hallez R, Letesson JJ, Vandenhaute J, De Bolle X: Gateway-based destination vectors for functional analyses of bacterial ORFeomes: application to the Min system in Brucella abortus . Appl Environ Microbiol 2007,73(4):1375–1379.PubMedCrossRef 32. Senior BW, Bradford NC, Simpson DS: The ureases of Proteus strains in relation to virulence for the urinary tract. J Med Microbiol 1980,13(4):507–512.PubMedCrossRef 33. Bradford MM: A rapid and sensitive method for the quantitation of microgram quantities of protein utilizing the principle of protein-dye binding. Anal Biochem 1976, 72:248–254.PubMedCrossRef 34. Rozen S, Skaletsky H: Primer3 on the WWW for general users and for biologist programmers. Methods Mol Biol 2000, 132:365–386.PubMed 35. BLAST with microbial genomes [http://​www.​ncbi.​nlm.​nih.​gov/​sutils/​genom_​table.​cgi] 36. Hanahan D: Studies on transformation of Escherichia coli with plasmids. J Mol Biol 1983,166(4):557–580.PubMedCrossRef 37.

J Bacteriol 2007, 189:1983–1997.CrossRefPubMed 47. Qiu X, Gurkar AU, Lory S: Interstrain transfer of the large pathogenicity island (PAPI-1) of Pseudomonas aeruginosa. Proc Natl Acad Sci USA 2006, 103:19830–19835.CrossRefPubMed 48. Marenda M, Barbe V, Gourgues G, Mangenot S, Sagne E, Citti C: A new integrative conjugative element occurs in Mycoplasma agalactiae as chromosomal and free circular forms. J Bacteriol 2006, 188:4137–4141.CrossRefPubMed 49. Haase J, Lanka E: A specific protease encoded by the conjugative

DNA transfer systems of IncP and Ti plasmids is essential for pilus synthesis. J Bacteriol 1997, 179:5728–5735.PubMed 50. Byrd DR, Matson SW: Nicking by transesterification: the reaction Raf inhibitor catalysed by a relaxase. Mol Microbiol 1997, 25:1011–1022.CrossRefPubMed 51. Lanka E, Wilkins BM: DNA processing reactions in bacterial conjugation. Annu Rev Biochem 1995, 64:141–169.CrossRefPubMed 52. Sekine M, Tanikawa S, Omata S, Saito M, Fujisawa

T, Tsukatani N, Tajima this website T, Sekigawa T, Kosugi H, Matsuo Y, Nishiko R, Imamura K, Ito M, Narita H, Tago S, Fujita N, Harayama S: Sequence analysis of three plasmids harboured in Rhodococcus erythropolis strain PR4. Environ Microbiol 2006, 8:334–346.CrossRefPubMed 53. Mills SD, Jasalavich CA, Cooksey DA: A two-component regulatory system required for copper-inducible expression of the copper resistance operon of Pseudomonas syringae. J Bacteriol 1993, 175:1656–1664.PubMed Guanylate cyclase 2C 54. Cha JS, Cooksey DA: Copper resistance in Pseudomonas syringae mediated by periplasmic and outer membrane proteins. Proc Natl Acad Sci USA 1991, 88:8915–8919.CrossRefPubMed

55. Mergeay M, Monchy S, Vallaeys T, Auquier V, Benotmane A, Bertin P, Taghavi S, Dunn J, Lelie D, Wattiez R:Ralstonia metallidurans , a bacterium specifically adapted to toxic metals: towards a catalogue of metal-responsive genes. FEMS Microbiol Rev 2003, 27:385–410.CrossRefPubMed 56. Kohler T, Michea-Hamzehpour M, Henze U, Gotoh N, Curty LK, Pechere JC: Characterization of MexE-MexF-OprN , a positively regulated multidrug efflux system of Pseudomonas aeruginosa. Mol Microbiol 1997, 23:345–354.CrossRefPubMed 57. Hansen LH, Johannesen E, Burmolle M, Sorensen AH, Sorensen SJ: Plasmid-encoded multidrug efflux-pump conferring resistance to olaquindox in Escherichia coli. Antimicrob Agents Chemother 2004, 48:3332–3337.CrossRefPubMed 58. Papadopoulos CJ, Carson CF, Chang BJ, Riley TV: Role of the MexAB-OprM Efflux Pump of Pseudomonas aeruginosa in Tolerance to Tea Tree ( Melaleuca alternifolia ) Oil and Its Monoterpene Components Terpinen-4-ol, 1,8-Cineole, and α-Terpineol. Appl Environ Microbiol 2008, 74:1932–1935.CrossRefPubMed 59. Siebers A, Altendorf K: K + -translocating Kdp-ATPases and other bacterial P-type ATPases. Alkali cation transport systems in prokaryotes (Edited by: Bakker EP). CRC Press, Boca Raton, Florida 1993, 225–252. 60.

Miranti CK, Brugge JS: Sensing the environment: a historical perspective on integrin signal transduction. Nat Cell Biol 2002, 4 (4) : E83–90.CrossRefPubMed 3. Hughes selleck compound PE, Pfaff M: Integrin affinity modulation. Trends Cell Biol 1998, 8 (9) : 359–364.CrossRefPubMed 4. Ridley AJ, Schwartz MA, Burridge K, Firtel RA, Ginsberg MH, Borisy G, Parsons JT, Horwitz AR: Cell migration: integrating signals from front to back. Science 2003, 302 (5651) : 1704–1709.CrossRefPubMed 5. Miyamoto S, Akiyama SK, Yamada KM: Synergistic roles for receptor occupancy and aggregation in integrin transmembrane function. Science 1995, 267 (5199) : 883–885.CrossRefPubMed

6. Stewart MP, McDowall A, Hogg N: LFA-1-mediated adhesion is regulated by cytoskeletal restraint and by a Ca2+-dependent protease, calpain. J Cell Biol 1998, 140 (3) : 699–707.CrossRefPubMed 7. van Kooyk Y, van Vliet SJ, Figdor CG: The actin cytoskeleton LEE011 regulates LFA-1 ligand binding through avidity rather than affinity changes. J Biol Chem 1999, 274 (38) : 26869–26877.CrossRefPubMed

8. Schwartz MA, Ginsberg MH: Networks and crosstalk: integrin signalling spreads. Nat Cell Biol 2002, 4 (4) : E65–68.CrossRefPubMed 9. Miyamoto S, Teramoto H, Gutkind JS, Yamada KM: Integrins can collaborate with growth factors for phosphorylation of receptor tyrosine kinases and MAP kinase activation: roles of integrin aggregation and occupancy of receptors. J Cell Biol 1996, 135 (6 Pt 1) : 1633–1642.CrossRefPubMed 10. Shaw LM: Integrin function in breast carcinoma progression. J Mammary Gland Biol Neoplasia 1999, 4 (4) : 367–376.CrossRefPubMed 11. Perou CM, Sorlie T, Eisen MB, Rijn M, Jeffrey SS, Rees CA, Pollack JR, Ross DT, Johnsen H, Akslen LA, Fluge O, Pergamenschikov A, Williams C, Zhu SX, Lønning PE, Børresen-Dale AL, Brown PO, Botstein D: Molecular portraits of human breast tumours. Nature 2000, 406 (6797) : 747–752.CrossRefPubMed 12. Rabinovitz I, Toker A, Mercurio AM: Protein kinase C-dependent mobilization of the alpha6beta4 integrin from hemidesmosomes and its association with actin-rich cell protrusions

drive the chemotactic migration of carcinoma cells. J Cell Biol 1999, 146 (5) : 1147–1160.CrossRefPubMed Ponatinib 13. Mariotti A, Kedeshian PA, Dans M, Curatola AM, Gagnoux-Palacios L, Giancotti FG: EGF-R signaling through Fyn kinase disrupts the function of integrin alpha6beta4 at hemidesmosomes: role in epithelial cell migration and carcinoma invasion. J Cell Biol 2001, 155 (3) : 447–458.CrossRefPubMed 14. Mainiero F, Pepe A, Yeon M, Ren Y, Giancotti FG: The intracellular functions of alpha6beta4 integrin are regulated by EGF. J Cell Biol 1996, 134 (1) : 241–253.CrossRefPubMed 15. Peterson EJ, Woods ML, Dmowski SA, Derimanov G, Jordan MS, Wu JN, Myung PS, Liu QH, Pribila JT, Freedman BD, Shimizu Y, Koretzky GA: Coupling of the TCR to integrin activation by Slap-130/Fyb. Science 2001, 293 (5538) : 2263–2265.CrossRefPubMed 16.

Nat Med X-396 2012, 18:684–692.PubMedCrossRef

47. Forsythe P, Inman MD, Bienenstock J: Oral treatment with live Lactobacillus reuteri inhibits the allergic airway response in mice. Am J Respir Crit Care Med 2007, 175:561–569.PubMedCrossRef 48. Karimi K, Inman MD, Bienenstock J, Forsythe P: Lactobacillus reuteri-induced regulatory T cells protect against an allergic airway response in mice. Am J Respir Crit Care Med 2009, 179:186–193.PubMedCrossRef 49. Olszak T, An D, Zeissig S, Vera MP, Richter J, Franke A, Glickman JN, Siebert R, Baron RM, Kasper DL, et al.: Microbial exposure during early life has persistent effects on natural killer T cell function. Science 2012, 336:489–493.PubMedCentralPubMedCrossRef 50. Noverr MC, Falkowski NR, McDonald RA, McKenzie AN, Huffnagle GB: Development of allergic airway disease in mice following antibiotic therapy and fungal microbiota increase: role of host genetics, antigen, and interleukin-13.

Infect Immun 2005, 73:30–38.PubMedCentralPubMedCrossRef 51. Russell SL, Gold MJ, Willing BP, Thorson L, McNagny KM, Finlay BB: Perinatal antibiotic treatment affects murine microbiota, immune responses and allergic asthma. Gut Microbes 2013,71(1):30–38. 52. Hufeldt MR, Nielsen DS, Vogensen FK, Midtvedt T, Hansen AK: Variation in the gut microbiota of laboratory mice is related anti-PD-1 antibody to both genetic and environmental factors. Comp Med 2010, 60:336–347.PubMed 53. Pang W, Stradiotto D, Krych L, Karlskov-Mortensen P, Vogensen FK, Nielsen DS, Fredholm M, Hansen AK: Selective inbreeding does not increase gut microbiota similarity in BALB/c mice. Lab Anim 2012, 46:335–337.PubMedCrossRef 54. Hufeldt MR,

Nielsen DS, Vogensen FK, Midtvedt T, Hansen AK: Family relationship of female breeders reduce the systematic inter-individual variation in the gut microbiota of inbred laboratory mice. Lab Anim 2010, 44:283–289.PubMedCrossRef 55. Bangsgaard Bendtsen KM, Krych L, Sorensen DB, Pang W, Nielsen DS, Josefsen K, Hansen LH, Sorensen SJ, Hansen AK: Gut microbiota composition is correlated to grid floor induced stress and behavior in the BALB/c mouse. PLoS One 2012, 7:e46231.PubMedCentralPubMedCrossRef 56. Cediranib (AZD2171) Duerkop BA, Clements CV, Rollins D, Rodrigues JL, Hooper LV: A composite bacteriophage alters colonization by an intestinal commensal bacterium. Proc Natl Acad Sci U S A 2012, 109:17621–17626.PubMedCentralPubMedCrossRef Competing interests The authors declare that they have no competing interests. Authors’ contributions KKB conceived and designed the study, carried out the animal work and DNA extractions, and drafted the manuscript. MR did the 16S data generation, analysis and participated in the design of the study and manuscript. SSC performed the cultivation and bacterial identification. KAK, LHH, STL and SJS participated in design and coordination and helped to draft the manuscript. All authors read and approved the final manuscript.”
“Background Legionellosis is acquired by inhalation or aspiration of Legionella spp.